Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C3H7NO2 |
Molecular Weight | 89.0932 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](N)C(O)=O
InChI
InChIKey=QNAYBMKLOCPYGJ-UWTATZPHSA-N
InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m1/s1
Molecular Formula | C3H7NO2 |
Molecular Weight | 89.0932 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16154544
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154544
D-alanine is an isomer of non-essential L-amino acid. D isomer is found in the cell walls of bacteria, but not in bacterial proteins. It was discovered, that being an endogenous agonist of the glycine site of the N-methyl-d-aspartate (NMDA) receptor, D-alanine can have beneficial effects on schizophrenia.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154544 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Identification of a G protein-coupled receptor specifically responsive to beta-alanine. | 2004 May 28 |
|
Cephalosporin-resistant pneumococci and sickle cell disease. | 2005 Aug |
|
D-Amino acid dipeptide production utilizing D-alanine-D-alanine ligases with novel substrate specificity. | 2005 Jun |
|
Conformational and quantitative characterization of oritavancin-peptidoglycan complexes in whole cells of Staphylococcus aureus by in vivo 13C and 15N labeling. | 2006 Apr 7 |
|
Enzymatic characterization and crystal structure analysis of the D-alanine-D-alanine ligase from Helicobacter pylori. | 2008 Sep |
|
ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds. | 2009 Feb 1 |
|
Comparative genomic analyses of nickel, cobalt and vitamin B12 utilization. | 2009 Feb 10 |
|
Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice. | 2009 Jan 29 |
|
Genome subtraction for novel target definition in Salmonella typhi. | 2009 Oct 11 |
|
Crystal structure of the Apo form of D-Alanine:D-Alanine ligase (DDl) from Streptococcus mutans. | 2010 Aug |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154544
100 mg/kg/day
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28286870
It was studied the effect of D-alanine (10 mM), D-leucine (10 mM), D-methionine (10 mM), D-tryptophan (10 mM), and D-tyrosine (10 uM and 1 mM) on biofilm formation in two commonly studied laboratory strains of P. aeruginosa: PAO1 and PA14. In strains PAO1 and PA14, the addition of D-amino acids did not result in an inhibitory effect on biofilm growth in 24-well plates. Repeating the study in 96-well plates confirmed the findings that D-amino acids do not inhibit biofilm formation of P. aeruginosa. It was concluded that D-amino acids only slow the production of biofilms rather than completely prevent biofilm formation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:17:38 GMT 2023
by
admin
on
Sat Dec 16 02:17:38 GMT 2023
|
Record UNII |
E3UDS4613U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID3045649
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
29949
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
E3UDS4613U
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
71080
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
15570
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
DB01786
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
206-418-1
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
m1467
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
57416
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
158286
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY | |||
|
338-69-2
Created by
admin on Sat Dec 16 02:17:38 GMT 2023 , Edited by admin on Sat Dec 16 02:17:38 GMT 2023
|
PRIMARY |